Alpha Tau Medical Ltd., (DRTS): Price and Financial Metrics

Alpha Tau Medical Ltd., (DRTS): $2.30

0.04 (-1.71%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add DRTS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#244 of 360

in industry

DRTS Price/Volume Stats

Current price $2.30 52-week high $3.65
Prev. close $2.34 52-week low $1.75
Day low $2.26 Volume 15,600
Day high $2.34 Avg. volume 31,614
50-day MA $2.29 Dividend yield N/A
200-day MA $2.53 Market Cap 160.24M

DRTS Stock Price Chart Interactive Chart >


Alpha Tau Medical Ltd., (DRTS) Company Bio


Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.


DRTS Latest News Stream


Event/Time News Detail
Loading, please wait...

DRTS Latest Social Stream


Loading social stream, please wait...

View Full DRTS Social Stream

DRTS Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!